Noel Karalus

2.2k total citations · 1 hit paper
31 papers, 1.5k citations indexed

About

Noel Karalus is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Emergency Medical Services. According to data from OpenAlex, Noel Karalus has authored 31 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 16 papers in Pulmonary and Respiratory Medicine and 7 papers in Emergency Medical Services. Recurrent topics in Noel Karalus's work include Pneumonia and Respiratory Infections (10 papers), Respiratory viral infections research (8 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers). Noel Karalus is often cited by papers focused on Pneumonia and Respiratory Infections (10 papers), Respiratory viral infections research (8 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers). Noel Karalus collaborates with scholars based in New Zealand, United States and Australia. Noel Karalus's co-authors include Graham Mills, Robert J. Hancox, Lata Jayaram, Conroy Wong, Glenda Sullivan, Christine Tuffery, Ray Cursons, David Milne, Wendy Fergusson and Cecilia Tong and has published in prestigious journals such as The Lancet, PLoS ONE and Journal of Clinical Microbiology.

In The Last Decade

Noel Karalus

31 papers receiving 1.4k citations

Hit Papers

Azithromycin for prevention of exacerbations in non-cysti... 2012 2026 2016 2021 2012 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial
    2012 404 citations Conroy Wong, Lata Jayaram et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Noel Karalus New Zealand 16 823 636 165 159 149 31 1.5k
Ivan Le Jeune United Kingdom 11 973 1.2× 1.0k 1.6× 412 2.5× 137 0.9× 45 0.3× 17 2.1k
José Blanquer Spain 25 339 0.4× 1.1k 1.8× 45 0.3× 129 0.8× 70 0.5× 63 1.7k
Joseph B. Philips United States 24 797 1.0× 936 1.5× 127 0.8× 100 0.6× 85 0.6× 83 2.3k
D H Rose United Kingdom 10 404 0.5× 848 1.3× 45 0.3× 115 0.7× 35 0.2× 15 1.2k
Richard H. Winterbauer United States 23 1.5k 1.9× 621 1.0× 635 3.8× 127 0.8× 135 0.9× 45 2.4k
Abdulaziz H. Alzeer Saudi Arabia 15 263 0.3× 246 0.4× 187 1.1× 144 0.9× 70 0.5× 37 863
Avigdor Mandelberg Israel 23 853 1.0× 687 1.1× 196 1.2× 119 0.7× 43 0.3× 47 1.4k
F. Manresa Spain 21 664 0.8× 859 1.4× 146 0.9× 134 0.8× 76 0.5× 66 1.5k
Shih‐Feng Liu Taiwan 23 575 0.7× 241 0.4× 128 0.8× 339 2.1× 84 0.6× 101 1.6k
Paola Faverio Italy 20 935 1.1× 475 0.7× 268 1.6× 166 1.0× 32 0.2× 75 1.6k

Countries citing papers authored by Noel Karalus

Since Specialization
Citations

This map shows the geographic impact of Noel Karalus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noel Karalus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noel Karalus more than expected).

Fields of papers citing papers by Noel Karalus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noel Karalus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noel Karalus. The network helps show where Noel Karalus may publish in the future.

Co-authorship network of co-authors of Noel Karalus

This figure shows the co-authorship network connecting the top 25 collaborators of Noel Karalus. A scholar is included among the top collaborators of Noel Karalus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noel Karalus. Noel Karalus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jayaram, Lata, Alain C. Vandal, Catherina L. Chang, et al.. (2021). Tiotropium treatment for bronchiectasis: a randomised, placebo-controlled, crossover trial. European Respiratory Journal. 59(6). 2102184–2102184. 20 indexed citations
2.
Chalmers, James D., Wim Boersma, Mike Lonergan, et al.. (2019). Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis. The Lancet Respiratory Medicine. 7(10). 845–854. 105 indexed citations
3.
Aung, Htin, Ray Cursons, Ronan O’Toole, et al.. (2019). Dispersal of Mycobacterium tuberculosis Driven by Historical European Trade in the South Pacific. Frontiers in Microbiology. 10. 2778–2778. 24 indexed citations
4.
Altenburg, Josje, James D. Chalmers, Mike Lonergan, et al.. (2019). Long term macrolide antibiotics for the treatment of bronchiectasis in adults - individual participant data meta-analysis. OA4945–OA4945. 3 indexed citations
5.
Cursons, Ray, Robert J. Durrant, Noel Karalus, et al.. (2017). Rapid molecular diagnosis of the Mycobacterium tuberculosis Rangipo strain responsible for the largest recurring TB cluster in New Zealand. Diagnostic Microbiology and Infectious Disease. 88(2). 138–140. 2 indexed citations
6.
Colangeli, Roberto, Ray Cursons, Noel Karalus, et al.. (2014). Whole Genome Sequencing of Mycobacterium tuberculosis Reveals Slow Growth and Low Mutation Rates during Latent Infections in Humans. PLoS ONE. 9(3). e91024–e91024. 64 indexed citations
7.
Chang, Catherina L., Graham Mills, Noel Karalus, et al.. (2013). Biomarkers of Cardiac Dysfunction and Mortality from Community-Acquired Pneumonia in Adults. PLoS ONE. 8(5). e62612–e62612. 36 indexed citations
8.
Wong, Conroy, Lata Jayaram, Noel Karalus, et al.. (2012). Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial. The Lancet. 380(9842). 660–667. 404 indexed citations breakdown →
9.
Chang, Catherine, Samuel Robinson, Graham Mills, et al.. (2011). Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD. Thorax. 66(9). 764–768. 180 indexed citations
10.
Cursons, Ray, et al.. (2011). Vitamin D, innate immunity and outcomes in community acquired pneumonia. Respirology. 16(4). 611–616. 80 indexed citations
11.
Chang, Catherina L., et al.. (2010). Predicting early mortality in acute exacerbation of chronic obstructive pulmonary disease using the CURB65 score. Respirology. 16(1). 146–151. 59 indexed citations
12.
Chang, Catherina L., et al.. (2009). Cardio‐selective and non‐selective beta‐blockers in chronic obstructive pulmonary disease: effects on bronchodilator response and exercise. Internal Medicine Journal. 40(3). 193–200. 29 indexed citations
13.
Subramaniam, Rathan M., et al.. (2009). The Geneva prognostic score and mortality in patients diagnosed with pulmonary embolism by CT pulmonary angiogram. Journal of Medical Imaging and Radiation Oncology. 53(4). 361–365. 15 indexed citations
14.
Subramaniam, Rathan M., et al.. (2007). Withholding anticoagulation after a negative computed tomography pulmonary angiogram as a stand‐alone imaging investigation: a prospective management study. Internal Medicine Journal. 37(9). 624–630. 8 indexed citations
15.
Chang, Catherina L., et al.. (2007). Audit of acute admissions of chronic obstructive pulmonary disease: inpatient management and outcome. Internal Medicine Journal. 37(4). 236–241. 28 indexed citations
16.
Subramaniam, Rathan M., et al.. (2006). Computed tomography pulmonary angiogram diagnosis of pulmonary embolism. Australasian Radiology. 50(3). 193–200. 5 indexed citations
17.
18.
Laing, Richard, Stephen T. Chambers, Chris Frampton, et al.. (2004). Community‐acquired pneumonia: influence of management practices on length of hospital stay. Internal Medicine Journal. 34(3). 91–97. 13 indexed citations
19.
Harrison, A C, et al.. (1999). Tuberculosis in immigrants and visitors.. PubMed. 112(1096). 363–5. 8 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ivan Le Jeune Breakdown of academic impact, for papers by José Blanquer Breakdown of academic impact, for papers by Joseph B. Philips Breakdown of academic impact, for papers by D H Rose Breakdown of academic impact, for papers by Richard H. Winterbauer Breakdown of academic impact, for papers by Abdulaziz H. Alzeer Breakdown of academic impact, for papers by Avigdor Mandelberg Breakdown of academic impact, for papers by F. Manresa Breakdown of academic impact, for papers by Shih‐Feng Liu Breakdown of academic impact, for papers by Paola Faverio
Rankless by CCL
2026